Royal Philips: Philips to become a global leader in patient care management solutions for the hospital and the home through the acquisition of BioTelemetry, Inc.
USD 72.00 per share; implied enterprise value of USD 2.8 billion (approx. EUR 2.3 billion)
Acquisition is a strong fit with Philips strategy to transform the delivery of healthcare: combination of Philips leading patient monitoring position in the hospital with BioTelemetry s leading cardiac diagnostics and monitoring position outside the hospital
With 2019 sales of USD 439 million, BioTelemetry
annually monitors over 1 million cardiac patients remotely; its portfolio includes wearable heart monitors,
AI-based data analytics and services
C
eographical expansion, portfolio innovation synergies
Philips to Become a Global Leader in Patient Care Management Solutions for the Hospital and the Home Through the Acquisition of BioTelemetry, Inc koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.
(1)
December 17, 2020
Companies to develop compatibility of Philips MR Ingenia 3.0T and 1.5T systems with the InSightec Exablate Neuro platform
Amsterdam, the Netherlands and Haifa, Israel -
Royal Philips, a global healthcare company focused on the therapeutic power of acoustic energy, today announced a collaboration to expand access to MR-guided focused ultrasound for incisionless neurosurgery. By developing compatibility between Philips advanced MR systems and the Exablate Neuro platform from InSightec, the two companies will support expanded access to MR-guided focused ultrasound for the treatment of Essential Tremor and other neurological disorders. The expansion of access to this innovative treatment option has the potential to significantly improve the patient and staff experience, enhance health outcomes and lower the cost of care.
December 17, 2020
Philips and InSightec partner to expand access to MR-guided focused ultrasound for incisionless neurosurgery
GlobeNewswire
December 17, 2020
Companies to develop compatibility of Philips’ MR Ingenia 3.0T and 1.5T systems with the InSightec Exablate Neuro platform
Amsterdam, the Netherlands and Haifa, Israel –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and
InSightec, a global healthcare company focused on the therapeutic power of acoustic energy, today announced a collaboration to expand access to MR-guided focused ultrasound for incisionless neurosurgery. By developing compatibility between Philips’ advanced MR systems and the Exablate Neuro platform from InSightec, the two companies will support expanded access to MR-guided focused ultrasound for the treatment of Essential Tremor and other neurological disorders. The expansion of access to this innovative treatment option has the potential to significantly improve the p
Philips and InSightec partner to expand access to MR-guided focused ultrasound for incisionless neurosurgery - Press Release digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.